drugset / Trial / NCT04955171
BEOVU Versus Eylea in the Treatment of Diabetic Macular Edema
RandomizedParallel-groupSingle-blindTreatment
Summary
Diabetic macular edema degeneration occur is a vision threatening condition. The investigators compare the efficacy of BEOVU and Eylea intravitreal treatment in the management
Timeline
- Start
- 2021-01-12
- Primary completion
- 2022-03
- Completion
- 2022-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Brolucizumab | Other / unclassified | — | Intravitreal |